Detalhe da pesquisa
1.
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration.
Ophthalmology
; 130(6): 588-597, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754174
2.
EFFECT OF RETINAL THICKNESS VARIABILITY ON VISUAL OUTCOMES AND FLUID PERSISTENCE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Post Hoc Analysis of the HAWK and HARRIER Studies.
Retina
; 42(3): 511-518, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34923515
3.
HAWK and HARRIER: Ninety-Six-Week Outcomes from the Phase 3 Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration.
Ophthalmology
; 128(1): 89-99, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32574761
4.
Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular Degeneration.
Ophthalmology
; 127(7): 963-976, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107066
5.
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration.
Ophthalmology
; 127(1): 72-84, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30986442
6.
Clinical comparison of 27-gauge and 23-gauge instruments on the outcomes of pars plana vitrectomy surgery for the treatment of vitreoretinal diseases.
Curr Opin Ophthalmol
; 31(3): 185-191, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32235251
7.
PATIENT-REPORTED VISUAL FUNCTION FROM THE OCRIPLASMIN FOR TREATMENT FOR SYMPTOMATIC VITREOMACULAR ADHESION, INCLUDING MACULAR HOLE (OASIS) STUDY.
Retina
; 40(7): 1331-1338, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31259807
8.
Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial.
Ophthalmology
; 126(8): 1155-1170, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30905643
9.
THE OASIS MP-1 SUBSTUDY: Characterization of the Effect of Ocriplasmin on Microperimetry Parameters.
Retina
; 39(2): 319-330, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29206755
10.
ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA: An Independent Analysis of Protocol i Study Data.
Retina
; 39(1): 88-97, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29474302
11.
Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial.
Lancet
; 390(10089): 50-61, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28526489
12.
Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Clinical Trial.
Ophthalmology
; 125(10): 1556-1567, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29716784
13.
CLINICAL EVIDENCE OF THE MULTIFACTORIAL NATURE OF DIABETIC MACULAR EDEMA.
Retina
; 38(2): 343-351, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28257378
14.
Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial.
Ophthalmology
; 124(9): 1296-1304, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28551167
15.
SCORE2 Report 2: Study Design and Baseline Characteristics.
Ophthalmology
; 124(2): 245-256, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27863843
16.
Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration: A Phase IIb, Multicenter, Randomized Controlled Trial.
Ophthalmology
; 124(2): 224-234, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28029445
17.
Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized Trial.
Ophthalmology
; 123(10): 2232-47, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27499517
18.
Ranibizumab Treatment for Pigment Epithelial Detachment Secondary to Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the HARBOR Study.
Ophthalmology
; 123(10): 2213-24, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27566855
19.
Enhanced Benefit in Diabetic Macular Edema from AKB-9778 Tie2 Activation Combined with Vascular Endothelial Growth Factor Suppression.
Ophthalmology
; 123(8): 1722-1730, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27236272
20.
Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration: A Randomized Controlled Study.
Ophthalmology
; 123(5): 1080-9, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26906165